Delivery Order SPE2DB22D2006-SPE2DB25FW3GP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,095.80 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, which was competitively awarded with no set-aside designation, is scheduled for completion by September 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order operates under a firm fixed price structure and represents a discrete transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $5,237.54 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This non-competitive delivery order, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price purchase under the company's existing contract vehicle. The vaccine will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's medical...
- The Defense Logistics Agency awarded a $5,239.50 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of July 28, 2025. This competitive, firm fixed-price contract was awarded on July 25, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $10,637.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This delivery order represents a non-competitive award issued under a child contract mechanism, leveraging AmerisourceBergen's established federal procurement relationship to fulfill military and federal medical supply requirements....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,297.80 firm fixed price delivery order for Rabavert rabies vaccine with diluents, effective August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,702.41 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed price delivery order, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The contract carries no set-aside designation and was competitively awarded. Performance will take place at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,845.59 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with a completion date of June 25, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $8,879.40 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This contract, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a firm fixed price, non-set-aside procurement executed under competitive conditions. The award was delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. The contract, issued September 2, 2025, with completion targeted for September 23, 2025, represents a firm fixed-price procurement with no set-aside designation. This award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,910.10 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 21, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3GPDelivery Order
The Defense Logistics Agency awarded a $27,582.69 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed price contract type. This delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, and performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This contract supports DLA's medical supply chain operations for federal healthcare needs, particularly serving military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, maintains a comprehensive $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical (designated SPE2DX) through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies globally. The current delivery order for rabies vaccine aligns with the company's established role as a critical vendor for federal pharmaceutical procurement and demonstrates its capability to fulfill specialized medical supply requirements across the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.6k | 8/11/25 |